ELRIG Target Innovation and Novel Screening Technologies 2025
二月 18, 2025
Berlin
德国
分享
关于活动
Join Beckman Coulter Life Sciences at the ELRIG Target Innovation & Novel Screening Technologies conference on February 18, 2025, at the VKU Headquarters in Berlin.
In the dynamic field of drug discovery, identifying and validating novel therapeutic targets is crucial for expanding the druggable genome and addressing unmet medical needs. This event will spotlight groundbreaking targets and the innovative methodologies and technologies that are propelling the tractable target space forward.
Esteemed experts from both academia and industry will gather to discuss the latest approaches, opportunities, and challenges in exploiting historically challenging and novel target classes using state-of-the-art methodologies.
Don’t miss the opportunity to hear from these confirmed speakers:
- Martin Schroeder – Novartis
- Katharina Duerr – Omass
- Marc Nazare – FMP
- Hauke Cornils – Evotec
- Lukas Friedrich – Merck Healthcare Kgaa
- Kamyar Hadian – Helmholtz Munich
Join us for a day of insightful discussions and networking with leaders in the field. Be sure to stop by to chat about how we can help streamline your workflows.
